NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

Press Release

NuVasive(R) Celebrates a Decade of Changing Spine Surgery at NASS 2013

SAN DIEGO, CA -- (Marketwired) -- 10/16/13 -- NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, featured its game-changing products and procedures and celebrated a decade of changing spine surgery at the 28th Annual North American Spine Society (NASS) Annual Meeting in New Orleans, La.

The company had a fantastic showing at NASS 2013, featuring a number of innovative products designed to expand market presence and penetration. Newly launched products like the Bendini® Spinal Rod Bending System and the XLIF Decade™ Plate, received strong surgeon interest.

"The excitement was absolutely palpable in the NuVasive booth at NASS this year," said NuVasive Chairman and Chief Executive Officer Alex Lukianov. "We experienced exceptional booth traffic, delivered an unprecedented number of product demonstrations, and hosted several well-attended educational surgeon presentations. The surgeon presentations focused on our procedurally integrated neuromonitoring solutions for minimally disruptive surgery, the XLIF® procedure, and game-changing new procedures and products, like Bendini, MAS® PLIF, and the PCM® Cervical Disc. I am very proud of the NuVasive team that worked diligently to make NASS 2013 a huge success."

At the meeting, NuVasive commemorated the Company's achievements over the last decade of changing spine surgery through its dedication to improving patient and surgical outcomes with a focus on Speed of Innovation®, Absolute Responsiveness®, and superior clinical results.

Throughout the past decade, hundreds of thousands of patients have benefitted from the Company's technological advancements. Patients can often walk the same day of surgery, experience less intra-operative blood loss, spend less time in the hospital, and return to work within four to six weeks.

The eXtreme Lateral Interbody Fusion (XLIF) procedure is just one example of how NuVasive has disrupted the spine industry with new and exciting technology. The Company continues to work with surgeons to improve each procedure to address additional indications. XLIF Corpectomy, is a minimally disruptive surgical solution for treating tumor and trauma patients, and XLIF Anterior Column Realignment (ACR™) can provide a less invasive method to address sagittal imbalance from the anterior column than traditional open procedures. Additionally, the recently launched XLIF Decade Plate System is the pinnacle in single-approach, lateral, spinal stabilization, and fusion with minimized exposure.

"By marrying the resources and technology of an innovative venture-backed company with ideas from thought leaders in the surgical community, we revolutionized spine surgery over the past 10 years," said Alex Lukianov. "It has been an incredible decade, but we are just getting started in transforming spine surgery. I am very excited to see how our innovative products and procedures will evolve and improve more patient lives through the next ten years as the first $1 Billion Start-Up!"

About NuVasive®

NuVasive is an innovative global medical device company that is changing spine surgery with minimally disruptive surgical products and procedurally-integrated solutions for the spine. The Company is the 4th largest player in the $8.2 billion global spine market.

NuVasive offers a comprehensive spine portfolio of more than 80 unique products developed to improve spine surgery and patient outcomes. The Company's principal procedural solution is its Maximum Access Surgery, or MAS®, platform for lateral spine fusion. MAS was designed to provide safe, reproducible, and clinically proven outcomes, and is a highly differentiated solution with fully integrated neuromonitoring, customizable exposure, and a broad offering of application-specific implants and fixation devices designed to address a variety of pathologies.

Having pioneered the lateral approach to spine fusion, NuVasive continues to be at the forefront of the spine industry's shift toward less invasive solutions. The Company's dedication to innovation continues to spawn game-changing technology such as the PCM® motion preserving disc for the cervical spine, XLIF® Corpectomy for tumor and trauma, and Armada®, which treats adult degenerative scoliosis in a less invasive fashion. The Company has also developed procedural solutions that completely redefine and improve upon traditional procedures like TLIF, PLIF, Posterior Fixation, and ALIF. NuVasive's solutions are increasingly being adopted internationally, as the Company lays the groundwork to continue growing as a global business and to offer industry-leading, Absolutely Responsive customer service to surgeons worldwide. NuVasive is focused on becoming a $1 Billion Start-up™; taking market share by maintaining a commitment to Superior Clinical Outcomes, Speed of Innovation®, and Absolute Responsiveness®.

NuVasive cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties that could cause actual growth and results to differ materially include, but are not limited to those risks and uncertainties more fully described in NuVasive's press releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

Investor Contact:
Tina Jacobsen
NuVasive, Inc.
Email Contact

Media Contact:
Nicole Collins
NuVasive, Inc.
Email Contact

Source: NuVasive, Inc.